Home > Cashflow Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Cash Inflow / Outflow ₹563 Cr₹475 Cr₹29 Cr₹-251 Cr₹-119 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Net Cash Inflow / Outflow ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹563 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹563 Cr
Mar2025₹475 Cr
Mar2024₹29 Cr
Mar2023₹-251 Cr
Mar2022₹-119 Cr

How is Net Cash Inflow / Outflow of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹563 Cr
18.65
Mar2025 ₹475 Cr
1,523.94
Mar2024 ₹29 Cr
Positive
Mar2023 ₹-251 Cr
Negative
Mar2022 ₹-119 Cr -

Compare Net Cash Inflow / Outflow of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹46,185.2 Cr 7% 6.7% -4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹454,914.0 Cr 7.3% 8.4% 13.1% Stock Analytics
DIVIS LABORATORIES ₹300,380.0 Cr 15.3% 24.1% 63% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,169.0 Cr 1% 2.5% 33.4% Stock Analytics
DR REDDYS LABORATORIES ₹114,933.0 Cr 1% 15.9% 14% Stock Analytics
CIPLA ₹114,478.0 Cr 0.4% 7.9% -6.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

7%

6.7%

-4.6%

SENSEX

5.9%

13%

-1.9%


You may also like the below Video Courses